31 May 2025Open access
Mpox: An emerging or re-emerging infection with a potential colossal burden on healthcare globallyPublisher siteAfrican Journal of Laboratory Medicine, Poxvirus research and outbreaks
Active, last published 2026
Larry
Chikwelu
Scholar“Research profile drawn from open scholarly records.”
Sefako Makgatho Health Sciences University
South Africa1
H-index
2
Citations
Larry has not officially claimed their profile. If you are Larry, claim it free.
Claim Your Profile
Pioneer
LOCKED
Pathfinder
LOCKED
Scholar
EARNED
Innovator
LOCKED
Inventor
LOCKED
Catalyst
LOCKED
Expert
UPGRADE
01 · About the work
What I study
research summary for Larry Chikwelu will appear here once their profile is updated.
02 · Reach
Publication output and reach
Larry's work has been cited 2 times across 2 active years. Bars show publications per year; the line shows cumulative citation totals across publications first appearing in each year.
04 · Where I am
Affiliations
Affiliation on published researchSefako Makgatho Health Sciences University, South AfricaDrawn from the institution listed on this researcher’s published work.
Research themes (UN SDGs)
05 · Selected work
Recent publications
3 works29 Nov 2024Open access1cites
The scourge of antimicrobial resistance: Containing a global crisisPublisher siteAfrican Journal of Laboratory Medicine, Antibiotic Use and Resistance
1 Jan 2024Open access1cites
Evidence of zoonotic rickettsiae in ixodid ticks of domestic animals in some communal farms in the Eastern Cape Province, South AfricaPublisher siteJournal of Advanced Veterinary and Animal Research, Vector-borne infectious diseases
Expert Academic Profiles go further
Citation trend analytics, exportable publication records, and direct enquiry routing from industry and funders.
Are you Larry?
Claim it to verify your details, connect with industry partners, and explore Fractional Domain Expert opportunities through MARATTO™.
African researchers are full of potential that too often goes unrecognised. Your MARATTO™ profile gives your work the commercial pathway it deserves.
Claim Your Profile
Free to claim · takes a minute to verify it’s you